Showing results (181-190 of 220) with videos related to

Sort By:
Pageof 22
Lung Cancer (Amsterdam, Netherlands)|December 22, 2024
STK11 mutations correlate with poor prognosis for advanced NSCLC treated with first-line immunotherapy or chemo-immunotherapy according to KRAS, TP53, KEAP1, and SMARCA4 statusAndrea De Giglio, Dario De Biase, Valentina Favorito, et al.
Diagnostics (Basel, Switzerland)|May 28, 2022
Molecular Characterization of Pancreatic Ductal Adenocarcinoma Using a Next-Generation Sequencing Custom-Designed Multigene PanelDeborah Malvi, Francesco Vasuri, Thais Maloberti, et al.
International Journal of Cancer|July 22, 2006
Association of aberrant methylation of tumor suppressor genes with tumor aggressiveness and BRAF mutation in papillary thyroid cancerShuiying Hu, Dingxie Liu, Ralph P Tufano, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|June 23, 2026
Genome-wide SNP-based Profiling of Loss of Heterozygosity Reveals Distinct Molecular Subgroup-specific Patterns in Gastrointestinal Stromal Tumors (GIST)Thais Maloberti, Margherita Nannini, Annalisa Astolfi, et al.
Critical Reviews in Oncology/Hematology|August 9, 2021
The tumor-agnostic treatment for patients with solid tumors: a position paper on behalf of the AIOM- SIAPEC/IAP-SIBioC-SIF Italian Scientific SocietiesAntonio Russo, Lorena Incorvaia, Umberto Malapelle, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 15, 2015
BRAF V600E and risk stratification of thyroid microcarcinoma: a multicenter pathological and clinical studyGiovanni Tallini, Dario de Biase, Cosimo Durante, et al.
The Journal of Clinical Endocrinology and Metabolism|February 13, 2014
Indoleamine 2,3-dioxygenase 1 (IDO1) is up-regulated in thyroid carcinoma and drives the development of an immunosuppressant tumor microenvironmentSonia Moretti, Elisa Menicali, Pasquale Voce, et al.
Future Oncology (London, England)|June 26, 2018
The role of clinical and molecular factors in low-grade gliomas: what is their impact on survival?Enrico Franceschi, Antonella Mura, Dario De Biase, et al.
Histopathology|April 15, 2025
Unveiling the molecular landscape and clinically relevant molecular heterogeneity of mucosal melanoma of the head and neck regionCostantino Ricci, Maria Vittoria Altavilla, Dario de Biase, et al.
Virchows Archiv : an International Journal of Pathology|October 16, 2023
Evaluation of an institutional series of low-grade oncocytic tumor (LOT) of the kidney and review of the mutational landscape of LOTCostantino Ricci, Francesca Ambrosi, Tania Franceschini, et al.
Pageof 22